期刊文献+

唑来膦酸治疗80例恶性肿瘤骨转移性疼痛 被引量:2

A clinical study for Zoledronic acid in the relief of pain due to bone metastatic malignancy
下载PDF
导出
摘要 目的评价注射用唑来膦酸治疗恶性肿瘤骨转移性疼痛镇疼效果和不良反应。方法80例恶性肿瘤骨转移性疼痛的患者,每次给予唑来膦酸注射液4mg,用生理盐水100m l稀释后静脉滴注,每3~4周1次,至少连续2次。结果临床镇痛骨转移止痛效果:显效27.5%(21/80),有效42.5%(34/80),总有效率70%,活动能力总改善率65%(52/80),生活质量改善总有效率67.5%(54/80)。主要不良反应为发热、一过性肌肉骨关节痛、流感样症状等,反应轻,不需特殊处理。结论唑来膦酸注射液治疗恶性肿瘤骨转移疼痛有效,时间短,不良反应轻,能显著改善患者的生活质量。 Objective To evaluate the efficacy and safety of zoledronic acid injection for the pain relief in patients with metastatic bone cancer.Methods 80 patients who have osseous metastasis pain were treated with 4 milligram Zoledronic acid injection diluted with 100 milliliter physiologic saline by intravenous drip infusion per 3 to 4 weeks.Two cycles of zoledronic acid injection have to be finished at least before the response can be evaluated.Results The effect of pain relieving :remarkable effect were 27.5(21/...
出处 《延安大学学报(医学科学版)》 2009年第1期17-18,共2页 Journal of Yan'an University:Medical Science Edition
关键词 唑来膦酸 骨转移性疼痛 不良反应 Zoledronic acid pain of osseous metastasis caused by malignant tumor adverse effect
  • 相关文献

参考文献1

二级参考文献5

  • 1[2]Coleman RE,Purohit OP.Osteoclast inhibition for the treatment of bone metastases.Cancer Treat Rev,1993,19(2):79~203
  • 2[4]Lipton A, Samll E, Saad F, et al. The new bisphonate, Zometa (zoledronci acid) decreases skeletal complications in both lytic and blastic lestic lesions: a comparision to pamidronate. Cancer Invest 2001,20(1):45~47
  • 3[5]Lipton A, Costa L, Ali S, et al. Use of bone turnover for monitoring bone metastases and response to therapy. Semminars in Oncology, 2001, 28(4): 254~259
  • 4[6]Ralston SH, Patel U, Fraser WD, et al. Comparison of three intravenous bisphosphonates in cancer-associated hypercalcemia. Lancet , 1989,20(2):180~182
  • 5金懋林,杨伯琴,雷兰英,高禹.帕米膦酸钠治疗骨转移引起疼痛的疗效观察[J].中华肿瘤杂志,1998,20(4):310-312. 被引量:46

共引文献5

同被引文献2

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部